CORR® Tumor Board: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.

Anderson, M. E., Wu, J. S., & Vargas, S. O. (2018). CORR® Tumor Board: Micrometastatic Drug Screening Platform Shows Heterogeneous Response to MAP Chemotherapy in Osteosarcoma Cell Lines.. Clinical Orthopaedics and Related Research, 476(7), 1396-1399.
Last updated on 04/21/2026
PubMed